USNA  Usana Health Sciences Inc.




Consumer Durables


Specialty Chemicals

Market Cap.


Vuru Grade


Current Price

+1.02 (+0.75%)

Growth Price

Overvalued by 35.01%

Stability Price

Undervalued by 9.49%

Company Metrics

  • P/E 19.49
  • P/S 1.9
  • P/B 5.58
  • EPS 7.01
  • Cash ROIC 59.74%
  • Cash Ratio 1.02
  • Dividend 0 / 0%
  • Avg. Vol. 136,220.00
  • Shares 12.80M
  • Market Cap. 1.75B

Company Description

USANA Health Sciences, Inc. develops, manufactures, distributes, and sells nutritional and personal care products worldwide. It offers two product lines, USANA Nutritionals and Sense. The USANA Nutritionals product line consists of essentials, which include vitamin and mineral supplements that provide a foundation of nutrition for various age groups; optimizers that are targeted supplements suppor... more

Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow


Are Analysts Bullish USANA Health Sciences, Inc. (NYSE:USNA) After Last Week? - 14 hours ago
Out of 3 analysts covering USANA Health Science (NYSE:USNA), 2 rate it “Buy”, 0 “Sell”, while 1 “Hold”. This means 67% are positive.
Zacks: Agents Arranged $137.67 Goal Value for USANA Health Sciences (NASDAQ:USNA) - Voice Chronicle
Oversold Conditions For USANA Health Sciences (USNA)
Forbes - Oct 7, 2015
In trading on Wednesday, shares of USANA Health Sciences Inc (NYSE: USNA) entered into oversold territory, hitting an RSI reading of 29.5, after changing hands as low as $120.00 per share.
Should You Buy Shares of USANA Health Sciences, Inc. (USNA)?
Insider Monkey (blog) - Nov 23, 2015
USANA Health Sciences, Inc. (NYSE:USNA) investors should pay attention to a decrease in hedge fund sentiment lately.
Company Shares of USANA Health Sciences, Inc. (NYSE:USNA) Drops by -0.68% - OTC Outlook
Monday Movers: Usana Health Sciences Incorporated (NYSE:USNA) - The Bulletin
USANA Health Sciences, Inc. (USNA) Updates FY15 Earnings Guidance
Dakota Financial News - Nov 3, 2015
USANA Health Sciences logo USANA Health Sciences, Inc. (NASDAQ:USNA) updated its FY15 earnings guidance on Tuesday. The company provided earnings per share guidance of $7.25-7.35 for the period, compared to the Thomson Reuters consensus ...
Usana Health (USNA) Marked As A Dead Cat Bounce Stock -
USANA Health Sciences (USNA) in Focus: Stock Rises 13.5% -
Pivotal Research Upgrades USANA Health Sciences Inc. (USNA) to Buy - Aug 5, 2015
Pivotal Research upgraded USANA Health Sciences Inc. (NYSE: USNA) from Hold to Buy with a price target of $200. Analyst Timothy S. Ramey noted hyper-growth in China.
USANA Health Sciences, Inc. (NYSE:USNA)'s Insider Myron Wentz Sells 7000 ... - Sep 14, 2015
Today, a sizable insider trading transaction was made. Myron Wentz, the director and an insider of USANA Health Sciences, Inc. (NYSE:USNA) 135.65 +3.69 2.80% sold precisely 7,000 shares of Usana Health Sciences Inc, worth around $968,226 U.S ...
Usana Health Sciences Inc (USNA) Files Form 4 Insider Selling : Myron W Wentz ...
Insider Trading Report - Nov 12, 2015
Usana Health Sciences Inc (USNA): Myron W Wentz , director of Usana Health Sciences Inc sold 10,000 shares on Nov 11, 2015.
Analyst Rating Summary for Usana Health Sciences Incorporated (NYSE:USNA) - The Bulletin
USANA Health Sciences Inc (NYSE:USNA) Q2 Results
Street Report - Sep 3, 2015
We analyze the earnings along side the following peers of USANA Health Sciences, Inc. - Nature's Sunshine Products, Inc., Avon Products, Inc., Nu Skin Enterprises, Inc. Class A, Revlon, Inc. Class A, Mannatech, Incorporated, ProPhase Labs, Inc., Reliv' ...
Company Shares of USANA Health Sciences, Inc. (NYSE:USNA) Rally 1.99%
OTC Outlook - Nov 1, 2015
Shares of USANA Health Sciences, Inc. (NYSE:USNA) appreciated by 1.99% during the past week but lost 5.01% on a 4-week basis.
New Ratings this Weekend: Usana Health Sciences Incorporated (NYSE:USNA) rated ... - The Bulletin
USANA Health Sciences (USNA) to Release Quarterly Earnings on Tuesday - Intercooler
USANA Health Sciences, Inc. Price Target Update
OTC Outlook - Nov 13, 2015
USANA Health Sciences, Inc. (NYSE:USNA): 3 analysts have set the short term price target of USANA Health Sciences, Inc. (NYSE:USNA) at $137.67. The standard deviation of short term price target has been estimated at $26.1, implying that the actual ...
USANA Health Sciences major shareholder Global Ltd Gull Sells 10000 Shares (USNA) - Voice Chronicle